Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chordomas”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Testing effectiveness (Phase 2)Study completedNCT02383498
What this trial is testing

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

Who this might be right for
Chordoma
NantCell, Inc. 24
Not applicableLooking for participantsNCT02838602
What this trial is testing

Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors

Who this might be right for
Malignant Tumors as Chordoma, Adenoid Cystic Carcinoma and Sarcoma
Hospices Civils de Lyon 250
Testing effectiveness (Phase 2)Looking for participantsNCT06794645
What this trial is testing

Pembrolizumab and Pemetrexed for Progressive Chordoma

Who this might be right for
ChordomasChordoma
Saint John's Cancer Institute 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Post-approval studies (Phase 4)Study completedNCT01344356
What this trial is testing

Stereotactic Body Radiotherapy for Head and Neck Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckNasopharyngeal CarcinomaSalivary Gland Cancer+5 more
Mercy Research 19
Early research (Phase 1)UnknownNCT01175109
What this trial is testing

Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma

Who this might be right for
Chordoma
Deric M Park MD 36
Early research (Phase 1)Study completedNCT04246671
What this trial is testing

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Who this might be right for
ChordomaHER2-positive Breast Cancer
Bavarian Nordic 37
Not applicableLooking for participantsNCT04087902
What this trial is testing

Long-Term Longitudinal QoL in Patients Undergoing EEA

Who this might be right for
Pituitary TumorMeningiomaRathke Cleft Cysts+5 more
Ohio State University 400
Large-scale testing (Phase 3)UnknownNCT01182779
What this trial is testing

Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base

Who this might be right for
ChordomaTumorTreatment
Heidelberg University 319
Not applicableLooking for participantsNCT05033288
What this trial is testing

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

Who this might be right for
Bone SarcomaChondrosarcomaChordoma+2 more
Mayo Clinic 72
Testing effectiveness (Phase 2)Looking for participantsNCT05407441
What this trial is testing

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

Who this might be right for
Atypical Teratoid Rhabdoid TumorINI1 (SMARCB1)-Deficient Primary CNS Malignant TumorsSMARCA4-deficient Primary CNS Malignant Tumors+4 more
Susan Chi, MD 49
Early research (Phase 1)Study completedNCT01924689
What this trial is testing

Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

Who this might be right for
Solid Tumor Malignancies
BioMed Valley Discoveries, Inc 24
Testing effectiveness (Phase 2)Study completedNCT03110744
What this trial is testing

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma

Who this might be right for
Chordoma
University Hospital Heidelberg 43
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Early research (Phase 1)Active Not RecruitingNCT04670679
What this trial is testing

A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 200
Not applicableStudy completedNCT00341627
What this trial is testing

Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families

Who this might be right for
Chordoma
National Cancer Institute (NCI) 56
Not applicableStudy completedNCT01567046
What this trial is testing

Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas

Who this might be right for
Childhood Alveolar Soft-part SarcomaChildhood AngiosarcomaChildhood Desmoplastic Small Round Cell Tumor+12 more
Children's Oncology Group 70
Testing effectiveness (Phase 2)WithdrawnNCT03647423
What this trial is testing

QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.

Who this might be right for
ChordomaUnresectable Malignant Neoplasm
ImmunityBio, Inc.
Early research (Phase 1)Study completedNCT01682746
What this trial is testing

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 5
Load More Results